Back
Citius Pharmaceuticals Vs. Moleculin Biotech Industry Stock Comparison
Sell
15
CTXR
Citius Pharmaceuticals
Last Price:
0.52
Seasonality Move:
-5.4%
Sell
29
MBRX
Moleculin Biotech
Last Price:
2.72
Seasonality Move:
-11.13%
Sell
15
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.52. The Score for CTXR is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
Moleculin Biotech (MBRX)
is a Sell
Is Moleculin Biotech a Buy, Sell or Hold?
- The current Moleculin Biotech [MBRX] share price is $2.75. The Score for MBRX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- MBRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
MBRX Stock Price Chart
What is Moleculin Biotech's stock price today?
-
The Moleculin Biotech share price today is $2.75
The current trend is relatively stagnant and MBRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CTXR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 40.78 | Sell |
Chaikin Money Flow: | 21586 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.51 - 0.59) | Sell |
Bollinger Bands (100): | (0.54 - 0.8) | Sell |
MBRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 57.15 | Buy |
Chaikin Money Flow: | 30415 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.37 - 2.57) | Buy |
Bollinger Bands (100): | (2.48 - 4.44) | Sell |
CTXR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.53 | Sell |
20-day SMA: | 0.53 | Sell |
50-day SMA: | 0.67 | Sell |
200-day SMA: | 0.71 | Sell |
8-day EMA: | 0.53 | Sell |
20-day EMA: | 0.55 | Sell |
50-day EMA: | 0.61 | Sell |
200-day EMA: | 0.72 | Sell |
MBRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.53 | Buy |
20-day SMA: | 2.47 | Buy |
50-day SMA: | 2.63 | Buy |
200-day SMA: | 5.6 | Sell |
8-day EMA: | 2.54 | Buy |
20-day EMA: | 2.51 | Buy |
50-day EMA: | 2.77 | Sell |
200-day EMA: | 5.11 | Sell |
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.10 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Moleculin Biotech Earnings Growth & MBRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.
Citius Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Moleculin Biotech Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |